Long-term tolerability and effectiveness of raltegravir in Japanese patients: Results from post-marketing surveillance.

by Naho Kuroishi, Asuka Watananbe, Ryuta Sakuma, Daniel J Ruzicka, Mitsuyoshi Hara
Published 2019-01-01

Switch rates, time-to-switch, and switch patterns of antiretroviral therapy in people living with human immunodeficiency virus in Japan, in a hospital-claim database

by Daniel J. Ruzicka, Naho Kuroishi, Nobuyuki Oshima, Ryuta Sakuma, Toshio Naito
Published 2019-06-01

Robust Enhancement of Lentivirus Production by Promoter Activation

by Naoto Suzuki, Takeshi Yoshida, Hiroaki Takeuchi, Ryuta Sakuma, Sayaka Sukegawa, Shoji Yamaoka
Published 2018-10-01

Suppressor of cytokine signaling 1 counteracts rhesus macaque TRIM5α-induced inhibition of human immunodeficiency virus type-1 production.

by Sayaka Sukegawa, Ryuta Sakuma, Seiga Ohmine, Hiroaki Takeuchi, Yasuhiro Ikeda, Shoji Yamaoka
Published 2014-01-01

The antiviral spectra of TRIM5α orthologues and human TRIM family proteins against lentiviral production.

by Seiga Ohmine, Ryuta Sakuma, Toshie Sakuma, Tayaramma Thatava, Hiroaki Takeuchi, Yasuhiro Ikeda
Published 2011-01-01